Bilirubin Testing Market, By Product (Bilirubinometers (Transcutaneous & Blood-Based), Bilirubin Reagent Kits & Assay Consumables, Test Cartridges & Strips, and Calibrators & Quality Controls), By Technology, By Application, By Patient, By End Use, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV5700
|
Published Date
July 2026
|
Pages
327
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Bilirubin Testing market size was valued at US$ 2,230.8 Million in 2025, expanding at a CAGR of 4.2% from 2026 to 2033.
A bilirubin laboratory test is a clinical chemistry diagnostic procedure used to measure the level of bilirubin, a yellow-orange pigment present in the blood, and serves as an important indicator for detecting conditions such as jaundice, liver dysfunction, and abnormal red blood cell breakdown. The test typically involves analyzing a venous blood sample using a diazo reagent-based colorimetric method to quantify bilirubin concentrations. During the analysis, bilirubin is categorized into conjugated (direct) bilirubin and unconjugated (indirect) bilirubin, with their respective levels measured using automated laboratory analyzers. By providing accurate assessment of bilirubin levels, this test supports the diagnosis of liver and blood-related disorders, enables effective disease monitoring, and assists healthcare professionals in making timely clinical decisions. For example, the World Health Organization (WHO) continues to emphasize universal access to quality diagnostic services as part of efforts to reduce the global burden of liver diseases and improve maternal and newborn healthcare.
Bilirubin Testing Market- Market Dynamics
Increasing Emphasis on Early Disease Detection to Propel Market Demand
The growing emphasis on early disease diagnosis is a key factor driving the growth of the bilirubin testing market. Rising awareness of neonatal jaundice, the increasing prevalence of liver diseases, and the growing need for rapid and accurate diagnostic testing in hospitals, diagnostic laboratories, and healthcare facilities are contributing to the demand for bilirubin tests. Early measurement of bilirubin levels enables healthcare professionals to identify liver dysfunction, hemolytic disorders, and neonatal hyperbilirubinemia at an early stage, facilitating timely treatment and improving patient outcomes. The increasing adoption of automated clinical chemistry analyzers has further enhanced the accuracy, speed, and efficiency of bilirubin testing in routine clinical practice.
Governments and international health organizations are also placing greater emphasis on strengthening early disease detection and diagnostic infrastructure. According to the Organisation for Economic Co-operation and Development (OECD), improving access to early diagnosis remains a priority for reducing disease burden and enhancing treatment outcomes. OECD data indicate that early-stage diagnosis rates vary significantly across diseases, with approximately 56% of breast cancer cases, 62% of cervical cancer cases, and 22% of colorectal cancer cases being detected at an early stage in assessed healthcare systems. These findings highlight the continued need for expanded screening programs, improved diagnostic capabilities, and timely clinical intervention. As healthcare systems worldwide continue to invest in preventive healthcare and early diagnostic services, demand for laboratory tests, including bilirubin testing, is expected to grow steadily, supporting the expansion of the global bilirubin testing market.
Bilirubin Testing Market- Segmentation Analysis:
The Global Bilirubin Testing market is segmented on the basis of Product, Technology, Application, Patient, End Use, and Region.
By product, bilirubin reagent kits and assay consumables account for a significant share of the global bilirubin testing market due to their essential role in routine diagnostic testing and their recurring usage across hospitals, diagnostic laboratories, and clinical chemistry laboratories. These products are required for the accurate measurement of total, direct (conjugated), and indirect (unconjugated) bilirubin levels, making them indispensable for diagnosing liver disorders, neonatal jaundice, and hemolytic diseases. The growing volume of diagnostic testing, coupled with increasing automation in clinical laboratories, continues to drive demand for high-quality reagent kits and consumables that offer consistent performance, accuracy, and compatibility with automated analyzers.
Manufacturers are continuously introducing advanced reagent kits to improve testing efficiency, reduce turnaround times, and enhance analytical accuracy. For example, in July 2025, Nova Biomedical introduced an upgraded version of its BR2 Bilirubin Test Kit, featuring pre-packaged assay consumables designed to simplify laboratory workflows and enable rapid measurement of total and direct bilirubin levels. Such product innovations, together with the expanding adoption of automated clinical chemistry testing, are expected to support the continued growth of the bilirubin reagent kits and assay consumables segment throughout the forecast period.
Bilirubin Testing Market- Geographical Insights
North America holds a significant share of the bilirubin testing market, supported by its advanced healthcare infrastructure, widespread neonatal jaundice screening programs, and the increasing prevalence of liver diseases. The region has a well-established network of hospitals, diagnostic laboratories, and clinical chemistry facilities that enables the routine use of automated bilirubin testing for the diagnosis and monitoring of liver disorders and neonatal hyperbilirubinemia. In addition, favorable reimbursement policies, high healthcare expenditure, and growing awareness of preventive healthcare continue to support market growth. The increasing burden of liver disease is further driving demand for bilirubin testing across the region. According to the U.S. Centers for Disease Control and Prevention (CDC), chronic liver disease remains a major public health concern in the United States, affecting millions of adults and contributing to a substantial number of deaths each year. The high prevalence of liver disorders, including cirrhosis and chronic liver disease, has increased the need for timely diagnosis and continuous patient monitoring, thereby supporting the adoption of advanced bilirubin testing systems and automated clinical chemistry analyzers across healthcare facilities.
France is emerging as an important market for bilirubin testing, driven by ongoing modernization of hospital laboratories, increasing adoption of automated clinical chemistry systems, and government initiatives aimed at strengthening diagnostic services. Healthcare providers are investing in advanced laboratory technologies to improve diagnostic accuracy, reduce turnaround times, and enhance patient care. The integration of automation, digital laboratory workflows, and high-throughput analyzers is accelerating the use of bilirubin testing in routine clinical practice. Furthermore, according to MedTech Europe, France represents one of the largest in vitro diagnostics (IVD) markets in Europe, reflecting strong investments in diagnostic infrastructure and laboratory modernization. The continued adoption of automated diagnostic platforms, molecular diagnostics, and digital laboratory solutions is expected to enhance the efficiency of clinical testing and support broader utilization of bilirubin testing across hospitals and diagnostic laboratories in France over the coming years.
Bilirubin Testing Market- Competitive Landscape:
The bilirubin testing market is characterized by the presence of major players such as Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., and Bio-Rad Laboratories, Inc.. These companies are strengthening their market positions through continuous innovations in diagnostic technologies, laboratory automation, and testing systems, while expanding their geographic presence and product portfolios. In November 2025, Abbott Laboratories acquired Exact Sciences to strengthen its diagnostics portfolio by integrating laboratory testing and precision diagnostic capabilities. This acquisition is expected to enhance Abbott’s presence in the laboratory diagnostics segment and strengthen its clinical testing capabilities. Such strategic initiatives are helping companies improve diagnostic solutions, accelerate innovation, and reinforce their competitive position in the bilirubin testing market.
Recent Developments:
- In March 2026, Siemens Healthineers AG launched the Atellica IM pTau217 and BDTau immunoassays for research use. These additions expand the company\'s Atellica IM portfolio and enhance its integrated clinical chemistry and immunoassay testing capabilities.
- In January 2025, Thermo Fisher Scientific Inc. acquired the Purification & Filtration Division of Solventum in a transaction valued at approximately USD 4.1 billion. The acquisition is expected to expand Thermo Fisher Scientific’s portfolio of analytical and clinical laboratory products used for diagnostic testing.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL BILIRUBIN TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- bioMérieux SA
- DiaSys Diagnostic Systems GmbH
- HORIBA Ltd.
- ELITechGroup SAS
- QuidelOrtho Corporation
- Sysmex Corporation
- Mindray Bio-Medical Electronics Co., Ltd.
- DiaSorin S.p.A.
- Erba Mannheim
- Ortho Clinical Diagnostics, Inc.
- Others
GLOBAL BILIRUBIN TESTING MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033
- Bilirubinometers (Transcutaneous & Blood-Based)
- Bilirubin Reagent Kits & Assay Consumables
- Test Cartridges & Strips
- Calibrators & Quality Controls
- Others
GLOBAL BILIRUBIN TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- POC Testing
- Laboratory-Based Testing
GLOBAL BILIRUBIN TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Routine & Pre-operative Health Screening
- Hemolytic Disorders Assessment
- Liver Function Testing (LFT)
- Neonatal Jaundice Screening and Monitoring
GLOBAL BILIRUBIN TESTING MARKET, BY PATIENT- MARKET ANALYSIS, 2020 - 2033
- Adults
- Pediatric Patients
- Neonates
GLOBAL BILIRUBIN TESTING MARKET, BY END USE- MARKET ANALYSIS, 2020 - 2033
- Maternity and Neonatal Clinics
- Diagnostic Laboratories
- Hospitals & NICUs
- Others
GLOBAL BILIRUBIN TESTING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Bilirubin Testing Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Bilirubin Testing Market Snippet by Product
2.1.2. Bilirubin Testing Market Snippet by Technology
2.1.3. Bilirubin Testing Market Snippet by Application
2.1.4. Bilirubin Testing Market Snippet by Patient
2.1.5. Bilirubin Testing Market Snippet by End Use
2.1.6. Bilirubin Testing Market Snippet by Country
2.1.7. Bilirubin Testing Market Snippet by Region
2.2. Competitive Insights
3. Bilirubin Testing Key Market Trends
3.1. Bilirubin Testing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Bilirubin Testing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Bilirubin Testing Market Opportunities
3.4. Bilirubin Testing Market Future Trends
4. Bilirubin Testing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Bilirubin Testing Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Bilirubin Testing Market Landscape
6.1. Bilirubin Testing Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Bilirubin Testing Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2025 & 2033 (%)
7.1.2. Bilirubinometers (Transcutaneous & Blood-Based)
7.1.3. Bilirubin Reagent Kits & Assay Consumables
7.1.4. Test Cartridges & Strips
7.1.5. Calibrators & Quality Controls
7.1.6. Others
8. Bilirubin Testing Market – By Technology
8.1. Overview
8.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
8.1.2. POC Testing
8.1.3. Laboratory-Based Testing
8.1.4. Others
9. Bilirubin Testing Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
9.1.2. Routine & Pre-operative Health Screening
9.1.3. Hemolytic Disorders Assessment
9.1.4. Liver Function Testing (LFT)
9.1.5. Neonatal Jaundice Screening and Monitoring
9.1.6. Others
10. Bilirubin Testing Market – By Patient
10.1. Overview
10.1.1. Segment Share Analysis, By Patient, 2025 & 2033 (%)
10.1.2. Adults
10.1.3. Pediatric Patients
10.1.4. Neonates
11. Bilirubin Testing Market – By End Use
11.1. Overview
11.1.1. Segment Share Analysis, By End Use, 2025 & 2033 (%)
11.1.2. Maternity and Neonatal Clinics
11.1.3. Diagnostic Laboratories
11.1.4. Hospitals & NICUs
11.1.5. Others
12. Bilirubin Testing Market – By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
12.2. North America
12.2.1. Overview
12.2.2. Bilirubin Testing Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.2.4. North America Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.2.5. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.2.6. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.2.7. North America Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.2.8. North America Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Bilirubin Testing Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.3.18. Denmark
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.18.3. Denmark Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.18.4. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.18.5. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.18.6. Denmark Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.3.18.7. Denmark Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.3.19. Rest of Europe
12.3.19.1. Overview
12.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.19.3. Rest of the Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.19.4. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.19.5. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.19.6. Rest of the Europe Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.3.19.7. Rest of the Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Bilirubin Testing Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.4.17. Taiwan
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.17.3. Taiwan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.17.4. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.17.5. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.17.6. Taiwan Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.4.17.7. Taiwan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.4.18. Vietnam
12.4.18.1. Overview
12.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.18.3. Vietnam Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.18.4. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.18.5. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.18.6. Vietnam Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.4.18.7. Vietnam Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.4.19. Rest of APAC
12.4.19.1. Overview
12.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.19.3. Rest of APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.19.4. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.19.5. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.19.6. Rest of APAC Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.4.19.7. Rest of APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Bilirubin Testing Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.5.8. LATAM Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Bilirubin Testing Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.6.15. Iran
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.15.3. Iran Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.6.15.4. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.15.5. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.15.6. Iran Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.6.15.7. Iran Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.6.16. Qatar
12.6.16.1. Overview
12.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.16.3. Qatar Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.6.16.4. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.16.5. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.16.6. Qatar Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.6.16.7. Qatar Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12.6.17. Rest of MEA
12.6.17.1. Overview
12.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.17.3. Rest of MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.6.17.4. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.17.5. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.17.6. Rest of MEA Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
12.6.17.7. Rest of MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
13. Key Vendor Analysis- Bilirubin Testing Industry
13.1. Competitive Benchmarking
13.1.1. Competitive Dashboard
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. Abbott Laboratories
13.2.2. F. Hoffmann-La Roche Ltd.
13.2.3. Siemens Healthineers AG
13.2.4. Thermo Fisher Scientific Inc.
13.2.5. Bio-Rad Laboratories, Inc.
13.2.6. bioMérieux SA
13.2.7. DiaSys Diagnostic Systems GmbH
13.2.8. HORIBA Ltd.
13.2.9. ELITechGroup SAS
13.2.10. QuidelOrtho Corporation
13.2.11. Sysmex Corporation
13.2.12. Mindray Bio-Medical Electronics Co., Ltd.
13.2.13. DiaSorin S.p.A.
13.2.14. Erba Mannheim
13.2.15. Ortho Clinical Diagnostics, Inc.
13.2.16. Others
14. 360 Degree AnalystView
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL BILIRUBIN TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- bioMérieux SA
- DiaSys Diagnostic Systems GmbH
- HORIBA Ltd.
- ELITechGroup SAS
- QuidelOrtho Corporation
- Sysmex Corporation
- Mindray Bio-Medical Electronics Co., Ltd.
- DiaSorin S.p.A.
- Erba Mannheim
- Ortho Clinical Diagnostics, Inc.
- Others
GLOBAL BILIRUBIN TESTING MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033
- Bilirubinometers (Transcutaneous & Blood-Based)
- Bilirubin Reagent Kits & Assay Consumables
- Test Cartridges & Strips
- Calibrators & Quality Controls
- Others
GLOBAL BILIRUBIN TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- POC Testing
- Laboratory-Based Testing
GLOBAL BILIRUBIN TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Routine & Pre-operative Health Screening
- Hemolytic Disorders Assessment
- Liver Function Testing (LFT)
- Neonatal Jaundice Screening and Monitoring
GLOBAL BILIRUBIN TESTING MARKET, BY PATIENT- MARKET ANALYSIS, 2020 - 2033
- Adults
- Pediatric Patients
- Neonates
GLOBAL BILIRUBIN TESTING MARKET, BY END USE- MARKET ANALYSIS, 2020 - 2033
- Maternity and Neonatal Clinics
- Diagnostic Laboratories
- Hospitals & NICUs
- Others
GLOBAL BILIRUBIN TESTING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
